NEW YORK (AP) — NEW YORK (AP) — Immunic, Inc. (IMUX) on Friday reported a loss of $42.3 million in its third quarter.

The New York-based company said it had a loss of 99 cents per share.

The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 82 cents per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMUX at https://www.zacks.com/ap/IMUX